Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.71 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.65 |
| ▸ | CES2 | O00748 | 3/20 | 0.65 |
| ▸ | CES1 | P23141 | 3/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | F3 | P13726 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | USP7 | Q93009 | 1/20 | 0.55 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.55 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31040450 | 0.87 | ALOX5 (0.79) | ALOX5CES2CES1PTPN1F3 | |
| SCHEMBL1047226 | 0.87 | ALOX5 (0.79) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL11179650 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL14071729 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL15475219 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL13144259 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL14071724 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL8897742 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL1785482 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 | |
| Katonic Acid SCHEMBL29148513 | 0.79 | CES1 (1.00) | ALOX5CES2CES1PTPN1F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S | 2011-01-27 | — | — | US | disclosed |
| EP-2011517-A1 | Polynucleotide binding complexes comprising sterols and saponin | Nordic Vaccine Technology A/S (DK) | 2009-01-07 | — | — | EP | disclosed |
| EP-1377320-B1 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY AS (DK) | 2008-10-01 | — | — | EP | disclosed |
| EP-1409009-A1 | THERAPEUTICAL VACCINATION | Nordic Vaccine Technology A/S (DK) | 2004-04-21 | — | — | EP | disclosed |
| EP-1377320-A2 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | Nordic Vaccine Technology A/S (DK) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002102407-A1 | THERAPEUTICAL VACCINATION | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-12-27 | — | — | WO | disclosed |
| WO-2002080981-A2 | POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS | NORDIC VACCINE TECHNOLOGY A/S (DK) | 2002-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020226-A1 | PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS | LSS, SNRPE, HLA-C | BCL2L1 3685/4885ALOX5 651/4885CES2 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.